Chemotactic migration of the CCR1/CCR2-expressing CLL cells into the secondary organs, such as lymph nodes, spleen, and/or liver, contributes, apparently, to the aggressive pathogenesis of the disease. The gene discussed is CCR1; the disease is B-cell chronic lymphocytic leukemia.